ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,572.07
-0.76%
US Tech 100
18,922.80
0.07%
다우존스 지수
41,433.48
-1.14%
Bitcoin
82,849.90
0.00%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Lucid Diagnostics Inc (LUCD) 시세

Lucid Diagnostics Inc

Lucid Diagnostics Inc (LUCD)

NASDAQ
1.22
0.03
(2.52%)
종가: 12 3월 5:00AM
15분 지연
1.2674
0.0474
( 3.89% )
시간외 거래: 8:56AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
1.2674
매수가
1.18
매도가
1.26
거래량
293,915
1.18 일간 변동폭 1.2399
0.6301 52주 범위 1.633
market_cap
75.211M
전일 종가
1.19
개장가
1.21
최근 거래 시간
70
@
1.26
마지막 거래 시간
재정 규모
US$ 355,760
VWAP
1.2104
평균 볼륨(3m)
520,507
발행 주식
59,342,479
배당수익률
-
주가수익률
-1.37
주당순이익(EPS)
-0.89
매출
2.43M
순이익
-52.67M

Lucid Diagnostics Inc 정보

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically hig... Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. 더 보기

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
본부
Wilmington, Delaware, USA
설립됨
-
Lucid Diagnostics Inc is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker LUCD. The last closing price for Lucid Diagnostics was US$1.19. Over the last year, Lucid Diagnostics shares have traded in a share price range of US$ 0.6301 to US$ 1.633.

Lucid Diagnostics currently has 59,342,479 shares in issue. The market capitalisation of Lucid Diagnostics is US$70.62 million. Lucid Diagnostics has a price to earnings ratio (PE ratio) of -1.37.

LUCD 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
06 3월 2025
LUCD (2.52%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
05 3월 2025
LUCD (2.52%)

Form 8-K - Current report
Edgar (US Regulatory)
04 3월 2025
LUCD (2.52%)

Form 8-K - Current report
Edgar (US Regulatory)
04 3월 2025
LUCD (2.52%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
22 2월 2025
LUCD (2.52%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.04743.885245901641.221.441.189526251.32038092CS
4-0.0526-3.984848484851.321.6331.167998441.40337662CS
120.450255.09055310820.81721.6330.75015205071.21527975CS
260.452455.5092024540.8151.6330.734584651.06133229CS
52-0.0026-0.2047244094491.271.6330.63013229921.00417684CS
156-2.3926-65.37158469953.663.660.63011627571.31411461CS
260-11.4826-90.059607843112.7513.50.63011749952.35480131CS

LUCD - Frequently Asked Questions (FAQ)

What is the current Lucid Diagnostics share price?
The current share price of Lucid Diagnostics is US$ 1.2674
How many Lucid Diagnostics shares are in issue?
Lucid Diagnostics has 59,342,479 shares in issue
What is the market cap of Lucid Diagnostics?
The market capitalisation of Lucid Diagnostics is USD 70.62M
What is the 1 year trading range for Lucid Diagnostics share price?
Lucid Diagnostics has traded in the range of US$ 0.6301 to US$ 1.633 during the past year
What is the PE ratio of Lucid Diagnostics?
The price to earnings ratio of Lucid Diagnostics is -1.37
What is the cash to sales ratio of Lucid Diagnostics?
The cash to sales ratio of Lucid Diagnostics is 29.83
What is the reporting currency for Lucid Diagnostics?
Lucid Diagnostics reports financial results in USD
What is the latest annual turnover for Lucid Diagnostics?
The latest annual turnover of Lucid Diagnostics is USD 2.43M
What is the latest annual profit for Lucid Diagnostics?
The latest annual profit of Lucid Diagnostics is USD -52.67M
What is the registered address of Lucid Diagnostics?
The registered address for Lucid Diagnostics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
Which industry sector does Lucid Diagnostics operate in?
Lucid Diagnostics operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
RAYRaytech Holding Ltd
US$ 1.69
(94.25%)
103.98M
TSVT2seventy bio Inc
US$ 4.945
(76.61%)
30.77M
HSAIHesai Group
US$ 24.10
(50.53%)
26.07M
SPHLSpringview Holdings Ltd
US$ 6.00
(47.06%)
1.62M
SYRSSyros Pharmaceuticals Inc
US$ 0.1334
(45.63%)
688.68M
WCTWellchange Holdings Company Limited
US$ 0.68417
(-72.74%)
37.49M
ARVNArvinas Inc
US$ 8.29
(-52.79%)
18.84M
LZMHLZ Technology Holdings Ltd
US$ 8.011
(-48.84%)
678.67k
HTCOHigh Trend International Group
US$ 1.41
(-33.80%)
165.06k
SPGCSacks Parente Golf Inc
US$ 0.1061
(-33.73%)
34.2M
SYRSSyros Pharmaceuticals Inc
US$ 0.1334
(45.63%)
688.68M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0402
(20.00%)
410.88M
NVDANVIDIA Corporation
US$ 108.76
(1.66%)
348.03M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.93
(7.45%)
301.97M
CUTRCutera Inc
US$ 0.1079
(-16.03%)
217.22M

LUCD Discussion

게시물 보기
georgie18 georgie18 4 월 전
LUCD...$1.08...Off my .90 alert...🥳

georgie18

Member Level
Re: georgie18 post# 384972

Thursday, November 07, 2024 8:57:15 AM

Post#
385327
of 385451
LUCD...$1.05...🥳...NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the manuscript for its multicenter ESOGUARD BE-1 study has been accepted for publication in The American Journal of Gastroenterology, the official journal of the American College of Gastroenterology (ACG). This is the fourth publication presenting clinical validation data for Lucid's EsoGuard® Esophageal DNA Test, and the second to demonstrate its strong performance in an intended-use screening population. Consistent with previous studies, EsoGuard showed high sensitivity and negative predictive value in detecting esophageal precancer (Barrett's Esophagus or BE).

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 9:48:42 AM

Post#
6
of 7
LUCD...9621...Trying Red to Green here...🥳

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 8:23:21 AM

Post#
384965
of 384971
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
chemist72 chemist72 4 월 전
What is the MoIDX Medicare Program?
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=35025
👍️0
georgie18 georgie18 4 월 전
LUCD...$1.05...🥳...NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the manuscript for its multicenter ESOGUARD BE-1 study has been accepted for publication in The American Journal of Gastroenterology, the official journal of the American College of Gastroenterology (ACG). This is the fourth publication presenting clinical validation data for Lucid's EsoGuard® Esophageal DNA Test, and the second to demonstrate its strong performance in an intended-use screening population. Consistent with previous studies, EsoGuard showed high sensitivity and negative predictive value in detecting esophageal precancer (Barrett's Esophagus or BE).

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 9:48:42 AM

Post#
6
of 7
LUCD...9621...Trying Red to Green here...🥳

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 8:23:21 AM

Post#
384965
of 384971
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
georgie18 georgie18 4 월 전
LUCD...9621...Trying Red to Green here...🥳

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 8:23:21 AM

Post#
384965
of 384971
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
georgie18 georgie18 4 월 전
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
Monksdream Monksdream 12 월 전
LUCD new 52 lo
👍️0
Monksdream Monksdream 1 년 전
LUCD new 52 week low
👍️0
ErnieBilco ErnieBilco 3 년 전
Should have listened to the chart telling me lower but I bought some at $2.39 and $2.21 for a starter. It has a $9+ PT
👍️0
makinezmoney makinezmoney 3 년 전
$LUCD: Not the EV Car Company...............


But you can easily get confused.



Now at $7.30 here in PreMarket



https://www.luciddx.com/





GO $LUCD
👍️0

최근 히스토리

NASDAQ
LUCD
Lucid Diagnostics
BOV
WEGE3M
WEG ON
NASDAQI
RESI
Strategic Residential & ...
LSE
BWNG
Brown (n)
LSE
QI35
Morg.st.b.v 24
BIT
S31303
Societe Generale Effekten
TG
NAQB
Nasdaq
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지